Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions

NCT02089295 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Oxycodone
DRUG: Oxycodone
DRUG: Oxycodone

Sponsor

Pain Therapeutics